INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE SUPPRESS LIPOPOLYSACCHARIDE-INDUCED NITRITE FORMATION IN MACROPHAGES

被引:38
|
作者
HAUSCHILDT, S
SCHEIPERS, P
BESSLER, WG
机构
[1] Institute of Immunobiology, University of Freiburg
关键词
D O I
10.1016/0006-291X(91)91898-M
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stimulating bone marrow derived macrophages with LPS results in the induction of NO-synthase as measured by NO2- formation. Inhibitors of poly(ADP-ribose)polymerase, namely nicotinamide, 3-aminobenzamide and 3-methoxybenzamide, prevented NO2- formation in a dose dependent manner. Inhibition was most effective if the inhibitors were added at the same time as LPS. When added 10h after exposure to LPS, a time at which expression of the enzyme had reached its maximum, no inhibition was observed. The inhibitors also blocked early events in activation such as protein and RNA-synthesis as well as DNA-synthesis. Thus prevention of NO2- formation may be related to inhibition of these events. Activation of macrophages by LPS was not accompanied by an increase but rather by a small decrease in ADP-ribosyltransferase activity. Whether this decrease plays a physiological role in activation needs further exploration. © 1991.
引用
收藏
页码:865 / 871
页数:7
相关论文
共 50 条
  • [31] Mechanism of radiosensitization by inhibitors of poly(ADP-ribose) polymerase (PARP)
    Hegan, Denise C.
    Glazer, Peter M.
    CANCER RESEARCH, 2011, 71
  • [32] Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
    Markman, Maurie
    WOMENS HEALTH, 2018, 14 : 1 - 6
  • [33] Novel poly(ADP-ribose) polymerase-1 inhibitors
    Dunn, Derek
    Husten, Jean
    Ator, Mark A.
    Chatterjee, Sankar
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 222 - 224
  • [34] Poly(ADP-ribose) polymerase inhibitors in prostate and urothelial cancer
    Broenimann, Stephan
    Lemberger, Ursula
    Bruchbacher, Andreas
    Shariat, Shahrokh F.
    Hassler, Melanie R.
    CURRENT OPINION IN UROLOGY, 2020, 30 (04) : 519 - 526
  • [35] Development of Poly (ADP-Ribose)Polymerase (PARP) Inhibitors in Oncology
    Jones, Philip
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 229 - +
  • [36] Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
    Prakash Jagtap
    Csaba Szabó
    Nature Reviews Drug Discovery, 2005, 4 : 421 - 440
  • [37] Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents
    Bryant, HE
    Helleday, T
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 : 959 - 961
  • [38] Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
    Jannetti, Stephen A.
    Zeglis, Brian M.
    Zalutsky, Michael R.
    Reiner, Thomas
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [39] Inhibition of efflux transporters by poly ADP-ribose polymerase inhibitors
    Deng, Feng
    Sistonen, Johanna
    Neuvonen, Mikko
    Niemi, Mikko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (04) : 428 - 436
  • [40] Mechanism of Radiosensitization by Inhibitors of Poly (ADP-Ribose) Polymerase (PARP)
    Glazer, P. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S87 - S88